hepatocyte
Cell therapyexperimental
A hepatocyte is a cell of the main parenchymal tissue of the liver. Hepatocytes make up 80% of the liver's mass. These cells are involved in:Protein synthesis Protein storage Transformation of carbohydrates Synthesis of cholesterol, bile salts and phospholipids Detoxification, modification, and excretion of exogenous and endogenous substances Initiation of formation and secretion of bile — Wikipedia
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01465100)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHepatocyte ↗
Also known as
- hepatocyte
- hepatocyte
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07276568 | Early Phase 1 (Phase 1) | Dec 1, 2025 | Capital Medical University |
| NCT00805610 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2014 | Virginia Commonwealth University |
| NCT01465100 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2011 | University of Pittsburgh |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Virginia Commonwealth University | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1